2BBBullish & Bearish
Eikon Therapeutics Inc. (EIKN) trades on NASDAQ. It operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry. Its current 2BB score is 62 out of 100.
Eikon Therapeutics Inc.’s current 2BB score is 62 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 63 | High |
| Momentum | 51 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 55 | Moderate |
| Headquarters | Millbrae, California, United States |
| Founded | 2019 |
| Employees | 384 |
| P/E ratio | 0.57 |
| 52-week range | $7.90 – $17.40 |